Barinthus Biotherapeutics plc (BRNS)
$0.74+0.00%Close
BUYRECOVERY · day 28
Key stats
- Market cap
- $30M
- Beta
- -0.36
- P/E (TTM)
- -0.72
- 1W
- +0.00%
- 1M
- +23.33%
- vs SPY 1W
- -0.42%
- vs SPY 1M
- +21.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BRNS?
- LOPJLB’s latest quantitative signal on Barinthus Biotherapeutics plc (BRNS) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is BRNS in?
- Barinthus Biotherapeutics plc (BRNS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Barinthus Biotherapeutics plc (BRNS) do?
- Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 …